Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-25-165499
Filing Date
2025-07-25
Accepted
2025-07-25 16:45:27
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d82956d424b5.htm 424B5 473578
2 GRAPHIC g82956g01a33.jpg GRAPHIC 44573
3 GRAPHIC g82956g58f53.jpg GRAPHIC 24453
  Complete submission text file 0001193125-25-165499.txt   570116
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 424B5 | Act: 33 | File No.: 333-281937 | Film No.: 251152149
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)